CDKN2A and neoplasm: In the subgroup of p16/HPV DNA-negative tumours (n = 168), 24-miRNA-positive (n = 11; 6.5%; Table S5) and 24-miRNA-negative cases (n = 157; 93.5%) did not differ regarding OS (Figure S3B).